Q2 2016 Holdings
Filed 2016-08-15 | 35 holdings | $53.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $46.2M | 832,549 | 86.5% |
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $6.4M | 2,237,066 | 11.9% |
| Allscripts Healthcare Solutions Inc(MDRX) | COM | 01988P108 | $610.0K | 48,000 | 1.1% |
| Incyte Corp(INCY) | COM | 45337C102 | $31.4K | 392,236 | 0.1% |
| bluebird bio Inc | COM | 09609G100 | $26.5K | 612,025 | 0.0% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $18.9K | 2,424,136 | 0.0% |
| La Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $18.8K | 1,176,146 | 0.0% |
| Avexis Inc | COM | 05366U100 | $18.1K | 476,367 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $15.4K | 209,701 | 0.0% |
| Kite Pharma Inc | COM | 49803L109 | $14.3K | 285,518 | 0.0% |
| Symmetry Surgical Inc | COM | 87159G100 | $12.1K | 922,215 | 0.0% |
| Spdr Gold Shares ETF(GLD) | GOLD SHS | 78463V107 | $10.5K | 83,000 | 0.0% |
| Atara Biotherapeutics Inc.(ATRAGBX) | COM | 046513107 | $10.5K | 465,874 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $9.8K | 2,429,149 | 0.0% |
| iShares 20+ Year Treasury Bond ETF(TLT) | 20 YR TR BD ETF | 464287432 | $6.3K | 45,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $6.1K | 2,026,894 | 0.0% |
| Intercept Pharmaceuticals Inc(ICPTUSD) | COM | 45845P108 | $5.6K | 39,500 | 0.0% |
| Celldex Therapeutics Inc | COM | 15117B103 | $5.6K | 1,264,227 | 0.0% |
| Omeros Corp(OMER) | COM | 682143102 | $5.5K | 526,788 | 0.0% |
| Viveve Medical Inc | COM | 92852W204 | $3.3K | 814,946 | 0.0% |
| Barclays Bank iPath Dow Jones-Ubs Coffee Subindex TR ETN(JOUSD) | ETN DJUBSCOFFE38 | 06739H297 | $3.2K | 144,200 | 0.0% |
| Corium International Inc | COM | 21887L107 | $3.0K | 852,961 | 0.0% |
| Invuity Inc | COM NEW | 46187J205 | $2.2K | 226,042 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $1.9K | 242,784 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $1.8K | 44,701 | 0.0% |
| Global Blood Therapeutics Inc | COM | 37890U108 | $1.6K | 97,138 | 0.0% |
| Masimo Corp(MASI) | COM | 574795100 | $1.4K | 25,900 | 0.0% |
| Accelerate Diagnostics Inc | COM | 00430H102 | $1.1K | 74,843 | 0.0% |
| CytRx Corp | COM PAR $.001 | 232828509 | $1.0K | 466,200 | 0.0% |
| Sensus Healthcare Inc | UNIT 99/99/9999 | 81728J208 | $1.0K | 155,000 | 0.0% |
| Mnkd 01/20/2017 PUT 3Put | PUT | 56400P201 | $912 | 4,385 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $716 | 131,052 | 0.0% |
| Biopharmx Corp | COM | 09072X101 | $455 | 700,636 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $382 | 31,693 | 0.0% |
| Nivalis Therapeutics Inc | COM | 65481J109 | $138 | 30,000 | 0.0% |